Correction to “A combination of a dermocosmetic and a sunscreen reduces acne severity and signs of post‐inflammatory hyperpigmentation in subjects with Fitzpatrick phototypes ranging from I to VI”
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAcne and Rosacea Treatments and Effects · Dermatologic Treatments and Research · Skin Protection and Aging
Shahab R , Rashed N . J Cosmet Dermatol. 2024 Sep;23(9):3060–3061. 10.1111/jocd.16390. Epub 2024 May 30. PMID: 38813844.38813844
In the title, the word “tinted” should be deleted and photototypes range from I to VI not from IV to VI.
The title should have read “A combination of a dermocosmetic and a sunscreen reduces acne severity and signs of post‐inflammatory hyperpigmentation in subjects with Fitzpatrick phototypes ranging from I to VI”.
In paragraph 2, the used sunscreen was not tinted and no local ethic committee approval was required for the conduct of this study.
This paragraph should have read “…1785 adults with a phototype ranging from I to VI with acne and PIHP applied a with proven efficacy and a sunscreen product (DC, Effaclar Duo (+); SS, Anthelios Shaka Fluid SPF 50+, both La Roche‐Posay Laboratoire Dermatologique) daily for 2 months.^3^ The study complied with legal local requirements, and is registered in the Clinicaltrials.gov data base (NCT05601960); all subjects provided written informed consent…”.
We apologize for these errors.
Rana Shahab MD and Nabila Rashed MD, the authors.